Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Quick Stats
Apr 02, 202654.9
AI Score
HOLD0.31
Volume Ratio
May 06, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
EBS Stock Summary
Last updated Apr 02, 2026
EBS is currently trading at $8.28, positioned below its 200-day moving average of $9.45, suggesting bearish momentum. The stock has a 52-week range of $4.02 to $14.06.
Technical Analysis: The 50-day moving average stands at $9.76, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.117, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.117, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates EBS at 54.9/100 with a HOLD recommendation.
EBS (Emergent Biosolutions, Inc.) Indicators
Last updated Apr 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.117 |
| CMF (20) | -0.117 |
| ROC (10) | 0.495 |
| ADX (14) | 39.038 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.437 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -60.87 |
| MFI (14) | 58.327 |
EBS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
EBS Price vs Max Options Open Interest
EBS Max Change In Options Open Interest
EBS Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
EBS Daily Out of Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
EBS Daily In the Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
EBS Most Active Options by Volume(near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Emergent Biosolutions, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
EBS Moving Averages Analysis
EBS (Emergent Biosolutions, Inc.) Simple Moving Averages
Moving Averages are last updated Apr 02, 2026
| Days | MA |
|---|---|
| 10 | 8.13 |
| 20 | 8.16 |
| 30 | 8.71 |
| 50 | 9.76 |
| 100 | 10.69 |
| 200 | 9.45 |
EBS Fundamental Analysis
| P/E (Forward) | 2.0773 |
| P/E (Trailing) | 8.9247 |
| Market Cap ($) | 429.7 million |
| Earnings/Share ($) | 0.93 |
| Net Proft Margin (%) | 0.0708 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.52 |
| EPS Estimate Next Year ($) | 0.23 |
| WallStreet Target Price ($) | 12 |
| Most Recent Quarter |